Please login to the form below

Not currently logged in
Email:
Password:

Orilissa

This page shows the latest Orilissa news and features for those working in and with pharma, biotech and healthcare.

AbbVie files blockbuster hopeful elagolix for uterine fibroids

AbbVie files blockbuster hopeful elagolix for uterine fibroids

Will face competition from Myovant rival. AbbVie is gunning for the second indication for its new women’s health product Orilissa, hoping to add uterine fibroids to its FDA approval last ... The active ingredient in Orilissa – oral

Latest news

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics